Secondary C805S Mutation in HER2 Gene Confers Acquired Resistance to HER2 Kinase Inhibitors in HER2 Mutant Lung Cancer

被引：0
|
作者：
Kosaka, Takayuki [1 ]
Endoh, Hideki [1 ]
Repellin, Claire [1 ]
Tanizaki, Junko [1 ]
Ercan, Dalia [1 ]
Capelletti, Marzia [1 ]
Jaenne, Pasi A. [1 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
HER2; NSCLC; Acquired resistance; Target therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI09.08
引用
收藏
页码：S296 / S296
页数：1
相关论文
共 50 条
  • [41] HER2 Dual ISH Determination of HER2 Gene Status in Breast Cancer: Interobserver Reproducibility
    Limbach, A. A. Lott
    Downs-Kelly, E. P.
    Papouchado, B. G.
    Tubbs, R. R.
    Lanigan, C.
    Booth, C. N.
    LABORATORY INVESTIGATION, 2012, 92 : 52A - 52A
  • [42] HER2 Dual ISH Determination of HER2 Gene Status in Breast Cancer: Interobserver Reproducibility
    Limbach, A. A. Lott
    Downs-Kelly, E. P.
    Papouchado, B. G.
    Tubbs, R. R.
    Lanigan, C.
    Booth, C. N.
    MODERN PATHOLOGY, 2012, 25 : 52A - 52A
  • [43] Inhibition of HER2 mutant non-small cell lung cancer using 3rd generation EGFR/HER2 inhibitors
    Robichaux, Jacqulyne P.
    Nilsson, Monique
    Fang, Bingliang
    Heymach, John V.
    CANCER RESEARCH, 2016, 76
  • [44] Non-genetic HER2 intratumoral heterogeneity with newly discovered HER2 positive tumour cells in gastric cancer: HER2 mRNA expression in amplified HER2 gene tumour cells without HER2 protein over-expression
    Nitta, H.
    Kaito, A.
    Lo, A.
    Murillo, A.
    Munroe, D.
    Ochiai, A.
    Kuwata, T.
    VIRCHOWS ARCHIV, 2020, 477 : S192 - S192
  • [45] HER2 and ovarian cancer
    Sarancone, S.
    Acosta Haab, G.
    Nocito, A.
    Frahm, I
    Lupo, E.
    Caceres, V
    VIRCHOWS ARCHIV, 2009, 455 : 13 - 13
  • [46] In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer
    Melanie Spears
    Karen J. Taylor
    Alison F. Munro
    Carrie A. Cunningham
    Elizabeth A. Mallon
    Chris J. Twelves
    David A. Cameron
    Jeremy Thomas
    John M. S. Bartlett
    Breast Cancer Research and Treatment, 2012, 132 : 463 - 470
  • [47] Quantitative measurements of HER2 expression and HER2: HER2 dimerization identify subgroups of HER2 positive metastatic breast cancer patients with different probabilities of response to trastuzumab treatment
    Huang, W.
    Lipton, A.
    Leitzel, K.
    Ali, S. M.
    Fuchs, E. M.
    Weidler, J.
    Chappey, C.
    Sperinde, J.
    Tan, Y.
    Jin, X.
    Paquet, A.
    Winston, J.
    Petropoulos, C.
    Kostler, W. J.
    Bates, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S86 - S86
  • [48] HER2 Mutated and Nonmutated Non-small Cell Lung Carcinomas Can Harbor Heterogeneous HER2 Gene Amplification and HER2 Protein Expression
    Castillon, Marine
    Bourhis, Amelie
    Quintin-Roue, Isabelle
    Uguen, Arnaud
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (04) : 321 - 326
  • [49] HER2 signaling regulates HER2 localization and membrane retention
    Jeong, Jaekwang
    Kim, Wonnam
    Kim, Lark Kyun
    VanHouten, Joshua
    Wysolmerski, John J.
    PLOS ONE, 2017, 12 (04):
  • [50] The trichotomy of HER2 expression confers new insights into the understanding and managing for breast cancer stratified by HER2 status
    Jiang, Mingxia
    Liu, Jiaxuan
    Li, Qiao
    Xu, Binghe
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (07) : 1324 - 1336
12345